Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues

Biochemical Pharmacology

Volumn 51, Issue 1, 1996, Pages 87-90

  Canada, Andrew T ^a   Roberson, Kathryn M ^a   Vessella, Robert L ^b   Trump, Donald L ^c   Robertson, Cary N ^a   Fine, Robert L ^a,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d College of Physicians and Surgeons ^*  (United States)

Author keywords

glutathione; glutathione S transferase; prostate cancer

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; PROSTATE SPECIFIC ANTIGEN;

ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; XENOGRAFT;

EID: 0030061291     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02157-4     Document Type: Article

References (21)

1. Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM and Ozols RF, Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res 44: 5427-5431, 1984.
2. Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S and Batist G, Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity. Cancer Chemother Pharmacol 30: 341-347, 1992.
3. Yang WZ, Begleiter A, Johnston JB, Israels LG and Mowat MR, Role of glutathione and glutathione S-transferase in chlorambucil resistance. Mol Pharmacol 41: 625-630, 1992.
4. Barranco SC, Townsend CM Jr, Weintraub B, Beasley EG, MacLean KK, Shaeffer J, Liu NH and Schellenberg K, Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Cancer Res 50: 3614-3618, 1990.
5. Canada AT, Herman L, Kidd K, Robertson C and Trump D, Glutathione depletion increases the cytotoxicity of melphalan to the androgen-insensitive prostate cancer cell line, PC-3. Cancer Chemother Pharmacol 32: 73-77, 1993.
6. Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD and Friedman HS, Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49: 6917-6922, 1989.
7. Ware JL, Paulson DF, Mickey GH and Webb KS, Spontaneous metastasis of cells of the human prostate carcinoma cel line PC-3 in athymic nude mice. J Urol 128: 1064-1067, 1982.
8. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP, LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
9. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW, Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979
10. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF, Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
11. Roberson KM and Robertson CN, Isolation and growth of human primary prostate epithelial cultures. Methods Cell Sci, in press.
12. Anderson ME, Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113: 548-564, 1985.
13. Habig WH, Pabst MJ and Jakoby WB, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
14. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
15. Klein LA, Prostatic carcinoma. N Engl J Med 300: 824-833, 1979.
16. Eisenberger MA, Bezerdjian L and Kalash S, A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma. Urol Clin North Am 14: 695-706, 1987.
17. Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Viña J and Estrela JM, Depletion of tumor glutathione in vivo by buthionine sulphoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth. Biochem J 292: 477-483, 1993.
18. Chiarodo A, Meeting report. National Cancer Institute Roundtable on Prostate Cancer: Future research directions. Cancer Res 51: 2498-2505, 1991.
19. Tew KD, Bomber AM and Hoffman SJ, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48: 3622-3625, 1988.
20. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B and Ringborg U, Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51: 94-98, 1991.
21. Lee FY, Vessey A, Rofstad E, Siemann DW and Sutherland RM, Heterogeneity of glutathione content in human ovarian cancer. Cancer Res 49: 5244-5248, 1989.